Category Archives: Hepatitis B, C

Hepatitis C in patients with human immunodeficiency virus infection: Diagnosis, natural history, meta-analysis of sexual and vertical transmission, and therapeutic issues

2000

Hepatitis C (HCV) infection occurs in as many as 33% of the patients with human immunodeficiency virus (HIV) infection. In view of their improved survival, liver disease will become more...

Response rates to pegylated interferon and ribavirin in HCV/HIV coinfection: A research synthesis

2007

Several recent trials have determined varying rates of response to pegylated interferon plus ribavirin (peg-IFN + RIB) in hepatitis C virus (HCV)/human immunodeficiency virus-coinfected patients. We sought to identify a...

Peginterferon plus ribavirin for chronic hepatitis C in patients with human immunodeficiency virus

2009

OBJECTIVES: The aim of this study was to assess the effects of peginterferon plus ribavirin for chronic hepatitis C in patients with human immunodeficiency virus (HIV). METHODS: Trials were identified...

Hepatitis C virus infection and risk of coronary artery disease: A systematic review of the literature

2012

Background: Several chronic infections have been associated with cardiovascular diseases, including Chlamydia pneumoniae, human immunodeficiency virus and viral hepatitis. This review evaluates the literature on the association between chronic hepatitis...

Using hepatitis A and B vaccination as a paradigm for effective HIV vaccine delivery

2007

BACKGROUND: An understanding of vaccine acceptance and uptake is imperative for successful vaccination of populations that will be primary targets for vaccination after a vaccine against HIV is developed and...

Disparities and risks of sexually transmissible infections among men who have sex with men in China: A meta-analysis and data synthesis

2014

BACKGROUND: Sexually transmitted infections (STIs), including Hepatitis B and C virus, are emerging public health risks in China, especially among men who have sex with men (MSM). This study aims...

Prevalence of tuberculosis, hepatitis C virus, and HIV in homeless people: A systematic review and meta-analysis

2012

BACKGROUND: 100 million people worldwide are homeless; rates of mortality and morbidity are high in this population. The contribution of infectious diseases to these adverse outcomes is uncertain. Accurate estimates...

Impact of human immunodeficiency virus infection on the course of hepatitis C virus infection: A meta-analysis

2009

Aim: To analyze the influence of human immunodeficiency virus (HIV) infection on the course of hepatitis C virus (HCV) infection. Methods: We performed a meta-analysis to quantify the effect of...

Meta-analysis: IL-28B genotype and sustained viral clearance in HCV genotype 1 patients

2012

Background Polymorphisms in the IL-28B region are a strong predictor of sustained virologic response (SVR) in individual studies of HCV genotype 1 patients receiving peginterferon (pegIFN) and ribavirin. Aim To...

Telaprevir: A Hepatitis C NS3/4A Protease Inhibitor

2012

Background: Telaprevir is a hepatitis C NS3/4A protease inhibitor approved by the US Food and Drug Administration as part of combination therapy for the management of chronic hepatitis C virus...

Factors influencing adherence in Hepatitis-C infected patients: A systematic review

2014

BACKGROUND: Adherence is a crucial point for the successful treatment of a hepatitis-C virus infection. Studies have shown that especially adherence to ribavirin is important.The objective of this systematic review...

Suppression of HBV by tenofovir in HBV/HIV coinfected patients: A systematic review and meta-analysis.

2013

BACKGROUND: Hepatitis B coinfection is common in HIV-positive individuals and as antiretroviral therapy has made death due to AIDS less common, hepatitis has become increasingly important. Several drugs are available...

Email 1 selected articles

Email 1 selected articles

Error! The email wasn't sent. Please try again.

Your email has been sent!